Skip to main content
. 2023 Oct 11;10:1799–1811. doi: 10.2147/JHC.S428980

Table 5.

Treatment-Related Adverse Events

Adverse Events Any Grade n(%) Grade 1–2 n(%) Grade 3 n(%) Grade 4 n(%)
Total 35(85.3) 28(68.3) 7(17.0)
Fatigue 10(24.4) 8(19.5) 2(4.9)
Decreased appetite 10(24.4) 7(17.1) 3(7.3)
Fever 13(31.7) 12(29.3) 1(2.4)
Nausea 7(17.1) 6(14.6) 1(2.5)
Vomiting 4(9.8) 3(7.3) 1(2.5)
Abdominal pain 5(12.2) 4(9.7) 1(2.5)
Hand-foot syndrome 6(14.8) 4(9.8) 1(2.5) 1(2.5)
Diarrhea 5(12.2) 5(12.2)
Hypertension 11(26.8) 9(21.9) 2(4.9)
Proteinuria 5(12.2) 3(7.2) 1(2.5) 1(2.5)
Skin rash 7(17.1) 5(12.1) 1(2.5) 1(2.5)
Thrombocytopenia 6(14.6) 6(14.6)
Hypothyroidism 7(17.1) 5(12.1) 2(5.0)
Abnormal liver function 26(63.4) 21(51.2) 4(9.7) 1(2.5)